<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01151436</url>
  </required_header>
  <id_info>
    <org_study_id>RD.03.CIP.29089</org_study_id>
    <secondary_id>2009-018163-28</secondary_id>
    <nct_id>NCT01151436</nct_id>
  </id_info>
  <brief_title>Global Management of Facial Rejuvenation With a New Range of Hyaluronic Acid Dermal Fillers</brief_title>
  <acronym>FRESH</acronym>
  <official_title>Global Management of Facial Rejuvenation With a New Range of Hyaluronic Acid Dermal Fillers - Investigator and Subject Satisfaction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Galderma</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Galderma</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess performance and tolerance as well as investigator and
      subject satisfaction linked to the global management of facial rejuvenation with a new range
      of hyaluronic acid dermal fillers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The range of fillers tested in this study includes 5 different hyaluronic acid dermal
      fillers: Emervel Touch, Emervel Classic, Emervel Deep, Emervel Volume and Emervel Lips.

      The study will last 6 month.

      Injections will be performed at baseline. If necessary, the investigator will perform
      touch-up injections at the following visit (3 weeks later).

      Investigator and subject satisfaction will be collected through questionnaires.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">November 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Full Face Global Aesthetic Improvement</measure>
    <time_frame>3 weeks after last injection</time_frame>
    <description>Global aesthetic improvement scale score from baseline:
-1: worse 0: no change
improved
much improved
very much improved</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Full Face Global Aesthetic Improvement</measure>
    <time_frame>3 months after last injection</time_frame>
    <description>Global aesthetic improvement scale score from baseline:
-1: worse 0: no change
improved
much improved
very much improved</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Full Face Global Aesthetic Improvement</measure>
    <time_frame>6 months after last injection</time_frame>
    <description>Global aesthetic improvement scale score from baseline:
-1: worse 0: no change
improved
much improved
very much improved</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>NASOLABIAL FOLDS SEVERITY ASSESSMENT</measure>
    <time_frame>baseline</time_frame>
    <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NASOLABIAL FOLDS SEVERITY ASSESSMENT</measure>
    <time_frame>3 weeks after last injection</time_frame>
    <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NASOLABIAL FOLDS SEVERITY ASSESSMENT</measure>
    <time_frame>3 months after last injection</time_frame>
    <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NASOLABIAL FOLDS SEVERITY ASSESSMENT</measure>
    <time_frame>6 months after last injection</time_frame>
    <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PERIORBITAL LINES SEVERITY ASSESSMENT</measure>
    <time_frame>baseline</time_frame>
    <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PERIORBITAL LINES SEVERITY ASSESSMENT</measure>
    <time_frame>3 weeks after last injection</time_frame>
    <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PERIORBITAL LINES SEVERITY ASSESSMENT</measure>
    <time_frame>3 MONTHS AFTER LAST INJECTION</time_frame>
    <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PERIORBITAL LINES SEVERITY ASSESSMENT</measure>
    <time_frame>6 MONTHS AFTER LAST INJECTION</time_frame>
    <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MARIONETTE LINES SEVERITY ASSESSMENT</measure>
    <time_frame>BASELINE</time_frame>
    <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MARIONETTE LINES SEVERITY ASSESSMENT</measure>
    <time_frame>3 WEEKS AFTER LAST INJECTION</time_frame>
    <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MARIONETTE LINES SEVERITY ASSESSMENT</measure>
    <time_frame>3 MONTHS AFTER LAST INJECTION</time_frame>
    <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MARIONETTE LINES SEVERITY ASSESSMENT</measure>
    <time_frame>6 MONTHS AFTER LAST INJECTION</time_frame>
    <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>UPPER LIP LINES SEVERITY ASSESSMENT</measure>
    <time_frame>BASELINE</time_frame>
    <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>UPPER LIP LINES SEVERITY ASSESSMENT</measure>
    <time_frame>3 WEEKS AFTER LAST INJECTION</time_frame>
    <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>UPPER LIP LINES SEVERITY ASSESSMENT</measure>
    <time_frame>3 MONTHS AFTER LAST INJECTION</time_frame>
    <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>UPPER LIP LINES SEVERITY ASSESSMENT</measure>
    <time_frame>6 MONTHS AFTER LAST INJECTION</time_frame>
    <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CHEEK FOLDS SEVERITY ASSESSMENT</measure>
    <time_frame>BASELINE</time_frame>
    <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CHEEK FOLDS SEVERITY ASSESSMENT</measure>
    <time_frame>3 WEEKS AFTER LAST INJECTION</time_frame>
    <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CHEEK FOLDS SEVERITY ASSESSMENT</measure>
    <time_frame>3 MONTHS AFTER LAST INJECTION</time_frame>
    <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CHEEK FOLDS SEVERITY ASSESSMENT</measure>
    <time_frame>6 MONTHS AFTER LAST INJECTION</time_frame>
    <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LIP ENHANCEMENT ASSESSMENT</measure>
    <time_frame>baseline</time_frame>
    <description>Lip fullness grading scale score:
0: very thin lip
thin lip
moderately thick lip
thick lip
full lip</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LIP ENHANCEMENT ASSESSMENT</measure>
    <time_frame>3 WEEKS AFTER LAST INJECTION</time_frame>
    <description>Lip fullness grading scale score:
0: very thin lip
thin lip
moderately thick lip
thick lip
full lip</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LIP ENHANCEMENT ASSESSMENT</measure>
    <time_frame>3 MONTHS AFTER LAST INJECTION</time_frame>
    <description>Lip fullness grading scale score:
0: very thin lip
thin lip
moderately thick lip
thick lip
full lip</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LIP ENHANCEMENT ASSESSMENT</measure>
    <time_frame>6 MONTHS AFTER LAST INJECTION</time_frame>
    <description>Lip fullness grading scale score:
0: very thin lip
thin lip
moderately thick lip
thick lip
full lip</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">77</enrollment>
  <condition>Facial Wrinkles</condition>
  <arm_group>
    <arm_group_label>hyaluronic acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>hyaluronic acid dermal fillers</intervention_name>
    <description>1 injection per indication and 1 touch-up injection if necessary</description>
    <arm_group_label>hyaluronic acid</arm_group_label>
    <other_name>Facial wrinkles</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Seeking tissue augmentation treatment on the face,

          -  Presenting a score of 3 (Moderately deep wrinkle)or 4 (Deep wrinkle) on the Lemperle
             Rating Scale (LRS) of both nasolabial folds.

        Exclusion Criteria:

          -  At risk in term of precautions, warnings and contra-indication referred in the package
             insert of the study devices,

          -  Who underwent previous injection of permanent filler in the injected area.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe KESTEMONT</last_name>
    <role>Principal Investigator</role>
    <affiliation>Investigational site Nice France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Galderma investigational site</name>
      <address>
        <city>Arras</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Galderma investigational site</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Galderma investigational site</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Galderma investigational site</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Galderma investigational site</name>
      <address>
        <city>Darmstadt</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 24, 2010</study_first_submitted>
  <study_first_submitted_qc>June 25, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 28, 2010</study_first_posted>
  <results_first_submitted>April 10, 2012</results_first_submitted>
  <results_first_submitted_qc>April 10, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 7, 2012</results_first_posted>
  <last_update_submitted>May 29, 2012</last_update_submitted>
  <last_update_submitted_qc>May 29, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 4, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Facial wrinkle correction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Facies</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Hyaluronic Acid</title>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="77"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="76"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Hyaluronic Acid</title>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="77"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54.5" spread="8.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>France</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Full Face Global Aesthetic Improvement</title>
        <description>Global aesthetic improvement scale score from baseline:
-1: worse 0: no change
improved
much improved
very much improved</description>
        <time_frame>3 weeks after last injection</time_frame>
        <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
        <group_list>
          <group group_id="O1">
            <title>Hyaluronic Acid</title>
          </group>
        </group_list>
        <measure>
          <title>Full Face Global Aesthetic Improvement</title>
          <description>Global aesthetic improvement scale score from baseline:
-1: worse 0: no change
improved
much improved
very much improved</description>
          <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="77"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>NASOLABIAL FOLDS SEVERITY ASSESSMENT</title>
        <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
        <time_frame>baseline</time_frame>
        <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
        <group_list>
          <group group_id="O1">
            <title>Hyaluronic Acid</title>
          </group>
        </group_list>
        <measure>
          <title>NASOLABIAL FOLDS SEVERITY ASSESSMENT</title>
          <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
          <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>wrinkle</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="146"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.4" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Full Face Global Aesthetic Improvement</title>
        <description>Global aesthetic improvement scale score from baseline:
-1: worse 0: no change
improved
much improved
very much improved</description>
        <time_frame>3 months after last injection</time_frame>
        <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
        <group_list>
          <group group_id="O1">
            <title>Hyaluronic Acid</title>
          </group>
        </group_list>
        <measure>
          <title>Full Face Global Aesthetic Improvement</title>
          <description>Global aesthetic improvement scale score from baseline:
-1: worse 0: no change
improved
much improved
very much improved</description>
          <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Full Face Global Aesthetic Improvement</title>
        <description>Global aesthetic improvement scale score from baseline:
-1: worse 0: no change
improved
much improved
very much improved</description>
        <time_frame>6 months after last injection</time_frame>
        <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
        <group_list>
          <group group_id="O1">
            <title>Hyaluronic Acid</title>
          </group>
        </group_list>
        <measure>
          <title>Full Face Global Aesthetic Improvement</title>
          <description>Global aesthetic improvement scale score from baseline:
-1: worse 0: no change
improved
much improved
very much improved</description>
          <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="76"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>NASOLABIAL FOLDS SEVERITY ASSESSMENT</title>
        <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
        <time_frame>3 weeks after last injection</time_frame>
        <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
        <group_list>
          <group group_id="O1">
            <title>Hyaluronic Acid</title>
          </group>
        </group_list>
        <measure>
          <title>NASOLABIAL FOLDS SEVERITY ASSESSMENT</title>
          <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
          <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>wrinkle</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="146"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>NASOLABIAL FOLDS SEVERITY ASSESSMENT</title>
        <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
        <time_frame>3 months after last injection</time_frame>
        <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
        <group_list>
          <group group_id="O1">
            <title>Hyaluronic Acid</title>
          </group>
        </group_list>
        <measure>
          <title>NASOLABIAL FOLDS SEVERITY ASSESSMENT</title>
          <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
          <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="71"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>wrinkle</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="142"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>NASOLABIAL FOLDS SEVERITY ASSESSMENT</title>
        <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
        <time_frame>6 months after last injection</time_frame>
        <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
        <group_list>
          <group group_id="O1">
            <title>Hyaluronic Acid</title>
          </group>
        </group_list>
        <measure>
          <title>NASOLABIAL FOLDS SEVERITY ASSESSMENT</title>
          <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
          <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="72"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>wrinkle</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>PERIORBITAL LINES SEVERITY ASSESSMENT</title>
        <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
        <time_frame>baseline</time_frame>
        <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
        <group_list>
          <group group_id="O1">
            <title>Hyaluronic Acid</title>
          </group>
        </group_list>
        <measure>
          <title>PERIORBITAL LINES SEVERITY ASSESSMENT</title>
          <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
          <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>WRINKLE</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.9" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>PERIORBITAL LINES SEVERITY ASSESSMENT</title>
        <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
        <time_frame>3 weeks after last injection</time_frame>
        <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
        <group_list>
          <group group_id="O1">
            <title>Hyaluronic Acid</title>
          </group>
        </group_list>
        <measure>
          <title>PERIORBITAL LINES SEVERITY ASSESSMENT</title>
          <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
          <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>WRINKLE</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>PERIORBITAL LINES SEVERITY ASSESSMENT</title>
        <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
        <time_frame>3 MONTHS AFTER LAST INJECTION</time_frame>
        <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
        <group_list>
          <group group_id="O1">
            <title>Hyaluronic Acid</title>
          </group>
        </group_list>
        <measure>
          <title>PERIORBITAL LINES SEVERITY ASSESSMENT</title>
          <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
          <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>WRINKLE</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>PERIORBITAL LINES SEVERITY ASSESSMENT</title>
        <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
        <time_frame>6 MONTHS AFTER LAST INJECTION</time_frame>
        <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
        <group_list>
          <group group_id="O1">
            <title>Hyaluronic Acid</title>
          </group>
        </group_list>
        <measure>
          <title>PERIORBITAL LINES SEVERITY ASSESSMENT</title>
          <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
          <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>WRINKLE</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>MARIONETTE LINES SEVERITY ASSESSMENT</title>
        <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
        <time_frame>BASELINE</time_frame>
        <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
        <group_list>
          <group group_id="O1">
            <title>Hyaluronic Acid</title>
          </group>
        </group_list>
        <measure>
          <title>MARIONETTE LINES SEVERITY ASSESSMENT</title>
          <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
          <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="68"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>WRINKLES</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="136"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.1" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>MARIONETTE LINES SEVERITY ASSESSMENT</title>
        <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
        <time_frame>3 WEEKS AFTER LAST INJECTION</time_frame>
        <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
        <group_list>
          <group group_id="O1">
            <title>Hyaluronic Acid</title>
          </group>
        </group_list>
        <measure>
          <title>MARIONETTE LINES SEVERITY ASSESSMENT</title>
          <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
          <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="68"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>WRINKLE</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="136"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>MARIONETTE LINES SEVERITY ASSESSMENT</title>
        <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
        <time_frame>3 MONTHS AFTER LAST INJECTION</time_frame>
        <population>ININTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
        <group_list>
          <group group_id="O1">
            <title>Hyaluronic Acid</title>
          </group>
        </group_list>
        <measure>
          <title>MARIONETTE LINES SEVERITY ASSESSMENT</title>
          <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
          <population>ININTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>WRINKLE</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="132"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>MARIONETTE LINES SEVERITY ASSESSMENT</title>
        <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
        <time_frame>6 MONTHS AFTER LAST INJECTION</time_frame>
        <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
        <group_list>
          <group group_id="O1">
            <title>Hyaluronic Acid</title>
          </group>
        </group_list>
        <measure>
          <title>MARIONETTE LINES SEVERITY ASSESSMENT</title>
          <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
          <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="67"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>WRINKLE</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="134"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>UPPER LIP LINES SEVERITY ASSESSMENT</title>
        <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
        <time_frame>BASELINE</time_frame>
        <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
        <group_list>
          <group group_id="O1">
            <title>Hyaluronic Acid</title>
          </group>
        </group_list>
        <measure>
          <title>UPPER LIP LINES SEVERITY ASSESSMENT</title>
          <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
          <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>WRINKLE</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.1" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>UPPER LIP LINES SEVERITY ASSESSMENT</title>
        <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
        <time_frame>3 WEEKS AFTER LAST INJECTION</time_frame>
        <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
        <group_list>
          <group group_id="O1">
            <title>Hyaluronic Acid</title>
          </group>
        </group_list>
        <measure>
          <title>UPPER LIP LINES SEVERITY ASSESSMENT</title>
          <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
          <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>WRINKLE</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>UPPER LIP LINES SEVERITY ASSESSMENT</title>
        <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
        <time_frame>3 MONTHS AFTER LAST INJECTION</time_frame>
        <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
        <group_list>
          <group group_id="O1">
            <title>Hyaluronic Acid</title>
          </group>
        </group_list>
        <measure>
          <title>UPPER LIP LINES SEVERITY ASSESSMENT</title>
          <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
          <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>WRINKLE</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>UPPER LIP LINES SEVERITY ASSESSMENT</title>
        <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
        <time_frame>6 MONTHS AFTER LAST INJECTION</time_frame>
        <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
        <group_list>
          <group group_id="O1">
            <title>Hyaluronic Acid</title>
          </group>
        </group_list>
        <measure>
          <title>UPPER LIP LINES SEVERITY ASSESSMENT</title>
          <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
          <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>WRINKLE</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>CHEEK FOLDS SEVERITY ASSESSMENT</title>
        <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
        <time_frame>BASELINE</time_frame>
        <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
        <group_list>
          <group group_id="O1">
            <title>Hyaluronic Acid</title>
          </group>
        </group_list>
        <measure>
          <title>CHEEK FOLDS SEVERITY ASSESSMENT</title>
          <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
          <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>WRINKLE</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>CHEEK FOLDS SEVERITY ASSESSMENT</title>
        <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
        <time_frame>3 WEEKS AFTER LAST INJECTION</time_frame>
        <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
        <group_list>
          <group group_id="O1">
            <title>Hyaluronic Acid</title>
          </group>
        </group_list>
        <measure>
          <title>CHEEK FOLDS SEVERITY ASSESSMENT</title>
          <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
          <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>WRINKLE</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>CHEEK FOLDS SEVERITY ASSESSMENT</title>
        <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
        <time_frame>3 MONTHS AFTER LAST INJECTION</time_frame>
        <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
        <group_list>
          <group group_id="O1">
            <title>Hyaluronic Acid</title>
          </group>
        </group_list>
        <measure>
          <title>CHEEK FOLDS SEVERITY ASSESSMENT</title>
          <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
          <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>WRINKLE</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>CHEEK FOLDS SEVERITY ASSESSMENT</title>
        <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
        <time_frame>6 MONTHS AFTER LAST INJECTION</time_frame>
        <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
        <group_list>
          <group group_id="O1">
            <title>Hyaluronic Acid</title>
          </group>
        </group_list>
        <measure>
          <title>CHEEK FOLDS SEVERITY ASSESSMENT</title>
          <description>Severity scored on Lemperle Rating Scale:
0: no wrinkles
just perceptible wrinkle
shallow wrinkle
moderately deep wrinkle
deep wrinkle, well-defined edges
very deep wrinkle redundant fold</description>
          <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>WRINKLE</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>LIP ENHANCEMENT ASSESSMENT</title>
        <description>Lip fullness grading scale score:
0: very thin lip
thin lip
moderately thick lip
thick lip
full lip</description>
        <time_frame>baseline</time_frame>
        <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
        <group_list>
          <group group_id="O1">
            <title>Hyaluronic Acid</title>
          </group>
        </group_list>
        <measure>
          <title>LIP ENHANCEMENT ASSESSMENT</title>
          <description>Lip fullness grading scale score:
0: very thin lip
thin lip
moderately thick lip
thick lip
full lip</description>
          <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>number of lips (upper or lower)</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="71"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>LIP ENHANCEMENT ASSESSMENT</title>
        <description>Lip fullness grading scale score:
0: very thin lip
thin lip
moderately thick lip
thick lip
full lip</description>
        <time_frame>3 WEEKS AFTER LAST INJECTION</time_frame>
        <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
        <group_list>
          <group group_id="O1">
            <title>Hyaluronic Acid</title>
          </group>
        </group_list>
        <measure>
          <title>LIP ENHANCEMENT ASSESSMENT</title>
          <description>Lip fullness grading scale score:
0: very thin lip
thin lip
moderately thick lip
thick lip
full lip</description>
          <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>number of lips (upper or lower)</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="71"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>LIP ENHANCEMENT ASSESSMENT</title>
        <description>Lip fullness grading scale score:
0: very thin lip
thin lip
moderately thick lip
thick lip
full lip</description>
        <time_frame>3 MONTHS AFTER LAST INJECTION</time_frame>
        <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
        <group_list>
          <group group_id="O1">
            <title>Hyaluronic Acid</title>
          </group>
        </group_list>
        <measure>
          <title>LIP ENHANCEMENT ASSESSMENT</title>
          <description>Lip fullness grading scale score:
0: very thin lip
thin lip
moderately thick lip
thick lip
full lip</description>
          <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>number of lips (upper or lower)</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>LIP ENHANCEMENT ASSESSMENT</title>
        <description>Lip fullness grading scale score:
0: very thin lip
thin lip
moderately thick lip
thick lip
full lip</description>
        <time_frame>6 MONTHS AFTER LAST INJECTION</time_frame>
        <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
        <group_list>
          <group group_id="O1">
            <title>Hyaluronic Acid</title>
          </group>
        </group_list>
        <measure>
          <title>LIP ENHANCEMENT ASSESSMENT</title>
          <description>Lip fullness grading scale score:
0: very thin lip
thin lip
moderately thick lip
thick lip
full lip</description>
          <population>INTENT TO TREAT ON OBSERVED POPULATION (NO REPLACEMENT OF MISSING VALUE)</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>number of lips (upper or lower)</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>During the study period (maximum of 24 weeks)</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Hyaluronic Acid</title>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="77"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="77"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>NASOPHARYNGITIS</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="77"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Any intent of the investigator to publish or disclose in any way the information requires the sponsor's prior written approval. The investigator shall provide their draft of such publication to sponsor to review and approval at least 2 months prior to the date of intended publication. Sponsor shall have the absolute right to determine whether information may be published by the investigator.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Ma May</name_or_title>
      <organization>Galderma</organization>
      <phone>+33 4 92 38 67 33</phone>
      <email>may.ma@galderma.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

